• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development

    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Enhatch Partners with Holo-Light to Deliver New Extended Reality Streaming Platform

    Study Confirms Safety, Accuracy of Vectorious' V-LAP In-Heart Sensor

    Norman Noble Achieves ISO 13485:2016 Certification

    Indian SMEs Gaining Access to Russian Medtech Market Amid Ukraine Conflict

    Quell Wearable Neuromodulation Device Wins De Novo Authorization
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development

    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Theranos Fraud Trial, Part II: The Blame Game Continues

    An Update on Surgical Robotics

    Letting the Light In: How Failure Analysis is the Cornerstone of Success

    Three Talent Strategies to Attract High-Demand Skills

    The Advantages of Bioburden Screening for Sterilization Validation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Xact Wire EDM Corp.

    Concise Engineering

    BMP Medical

    JBC Technologies

    Fusion Biotec Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    ‘Right to Repair’: Separating Fact from Fiction

    Taking a Holistic Approach to Decentralized Clinical Trials (DCTs)

    Investment in Health Startups Drops

    The Power of Leveraging Customer Relationships

    Cost Effective & Efficient Wire EDM Techniques
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Xact Wire EDM Corp.

    Concise Engineering

    BMP Medical

    JBC Technologies

    Fusion Biotec Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    15 Years of Consi-stent Medtech Progress

    ...

    Related CONTENT
    • FDA Initiates Device Development Challenge to Help Combat Opioid Crisis
    • Boston Scientific Launches HeartLogic Heart Failure Diagnostic in Europe
    • FDA Approves Abbott's Xience Sierra Everolimus-Eluting Coronary Stent
    • 3 Critical Considerations for U.S. Medical Device Commercialization
    • Boston Scientific Responds to '60 Minutes' Transvaginal Mesh Report
    Sam Brusco, Associate Editor06.04.18
    Though merely 15 years ago, given the breakneck pace of innovation these days, 2003 seems a world away in terms of science and technology. It was the year the Concorde supersonic jet made its final flight; the year Kodak released the first digital camera with an organic light-emitting diode (OLED) display; and the year the National Human Genome Research Institute and the Department of Energy unveiled the successfully completed Human Genome Project, the culmination of a 13-year effort to sequence the three billion DNA letters in the human genome.

    2003 also marked Medical Product Outsourcing’s flagship issue, featuring the very first Top 30 Global Medical Device Companies report (this year’s version to be featured next month—stay tuned).

    That year’s list of the elite was championed by global medical device, drug, and consumer products company Johnson & Johnson, which would remain at the top spot for over a decade. J&J’s $11.6 billion in medical device revenue now seems paltry compared to 2017’s leader—Medtronic plc—which touted $28.8 billion in sales.

    Partially responsible for J&J’s windfall in 2003 resulted from Cordis Corporation’s (then a J&J business, now owned by Cardinal Health) April launch of a landmark treatment for coronary artery disease, and the first commercial device of its type—the Cypher drug-eluting stent, or DES for short.

    Cordis’ Cypher DES was hailed as the first combination drug-device intended to help reduce restenosis (blockage) of a coronary artery treated with a stent. Restenosis was then—and continues to be—an enormous challenge in long-term stent implantations used for interventional cardiology treatment. To prevent it, Cypher was coated in sirolimus, a macrolide compound that is also used to prevent organ transplant rejection and treat LAM—a rare, progressive, and systemic lung disease.

    “Cordis is very pleased to bring this remarkable and innovative treatment to patients, hospitals, and interventional cardiologists,” said then Johnson & Johnson Company Group Chairman Robert Croce upon Cypher’s U.S. launch. “Clinical evidence and experience with more than 50,000 patients treated to date in nearly 60 countries suggests the Cypher Stent represents the beginning of a new era in interventional cardiology—an era in which the combination of drugs and devices substantially improves patient outcomes.”

    DES technology was regarded to be such a significant improvement on current bare metal stent technology that the Centers for Medicare and Medicaid services (CMS) approved Cypher’s incremental reimbursement in August 2002, a full nine months before J&J launched Cypher in the U.S. The new policy provided significant incremental reimbursement over and above 2003’s bare metal stent reimbursement levels—undoubtedly due to Cypher’s demonstrated sustained reduction in blockage incidence by over 90 percent in Cordis’ landmark U.S. SIRIUS trial.

    A number of other medical technology giants were racing to commercialize their own DES products that year as well—J&J was simply the first to reach the U.S. market, granting it a sizeable head start. Around the same time J&J was gearing up to launch Cypher, Boston Scientific Corp. had achieved CE mark approval for its Taxus paclitaxel-eluting coronary stent. Taxus launched in the U.S. in March 2004, almost a full year behind Cypher. Paclitaxel, Boston Scientific’s drug of choice for the Taxus DES, is also used as a chemotherapy medication to treat a number of types of cancer.

    “The approval of the Taxus system marks an important opportunity for clinicians in the United States,” said Gregg Stone, M.D., then vice chairman of the Cardiovascular Research Foundation at the Lenox Hill Heart and Vascular Institute in New York, and principal investigator of the Taxus IV clinical trial. “In paclitaxel, we now have a multi-functional drug that is safe and highly effective. The Taxus system has shown impressive results across a wide range of patients. Its performance has been particularly impressive in challenging cases such as patients with diabetes, small vessels, and long lesions.”

    Guidant Corporation—which Boston Scientific acquired in 2015, after settling a lawsuit with J&J over the deal—had its own stent in the ring around that time, this one coated in everolimus, a sirolimus derivative used to prevent organ transplant rejection and treat renal cell cancer. However, rather than bringing its product to market itself, in February 2004 Guidant began a deal with Cordis to co-promote Cypher and assist the company in developing a Cypher stent utilizing Guidant’s stent delivery system. The agreement granted Guidant immediate entry into the U.S. DES market and settled ongoing stent-related patent disputes between the companies.

    Medtronic was also in the midst of clinical trials for its own Endeavor phosphorylcholine-coated DES in 2003, but did not achieve FDA approval and launch of the device until 2008, though it was the first DES approved in four years. Phosphorylcholine, unlike the other drug compounds used previously, is exclusively meant to prevent coronary artery blockage.

    Today, a majority of stents used in interventional cardiology procedures are coated in some antiproliferative pharmaceutical agent to prevent restenosis. J&J exited the DES market in 2011 due to safety concerns and fierce competition from rival products, but the market remains strong—according to Grand View Research, it was valued at $5.6 billion in 2015 with major players Boston Scientific, Medtronic, Abbott Laboratories, Biosensors International, Biotronik, Lepu Medical Technology, Terumo Medical, Cook Medical, Shandong JW Medical Systems, and Stentys leading the charge. 
    Related Searches
    • sales
    • sirolimus
    • cancer
    • fda
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    FDA Initiates Device Development Challenge to Help Combat Opioid Crisis FDA Initiates Device Development Challenge to Help Combat Opioid Crisis
    Boston Scientific Launches HeartLogic Heart Failure Diagnostic in Europe Boston Scientific Launches HeartLogic Heart Failure Diagnostic in Europe
    FDA Approves Abbott FDA Approves Abbott's Xience Sierra Everolimus-Eluting Coronary Stent
    3 Critical Considerations for U.S. Medical Device Commercialization 3 Critical Considerations for U.S. Medical Device Commercialization
    Boston Scientific Responds to Boston Scientific Responds to '60 Minutes' Transvaginal Mesh Report
    FDA Seeks Permanent Injunctions Against Two Stem Cell Clinics FDA Seeks Permanent Injunctions Against Two Stem Cell Clinics
    Driving Innovation and Improving Quality with 3D Printing Driving Innovation and Improving Quality with 3D Printing
    Boston Scientific Closes NxThera Acquisition Boston Scientific Closes NxThera Acquisition
    Quality Nightmares #38: Audit Selection Quality Nightmares #38: Audit Selection
    Software Validation: How It Should Be Done Software Validation: How It Should Be Done
    Positive Late-Breaking Data Unveiled for Boston Scientific Positive Late-Breaking Data Unveiled for Boston Scientific's Deep Brain Stimulation Study
    FDA Authorizes First Test for Emerging Pathogen Candida Auris FDA Authorizes First Test for Emerging Pathogen Candida Auris
    FDA Releases Medical Device Safety Action Plan in Effort to Modernize Approach FDA Releases Medical Device Safety Action Plan in Effort to Modernize Approach
    Boston Scientific Prevails In European Patent Dispute With Edwards Boston Scientific Prevails In European Patent Dispute With Edwards
    Boston Scientific Acquires nVision Medical for Up to $275M Boston Scientific Acquires nVision Medical for Up to $275M

    Related Breaking News

    • Diagnostics | Digital Health | Neurological
      FDA Initiates Device Development Challenge to Help Combat Opioid Crisis

      FDA Initiates Device Development Challenge to Help Combat Opioid Crisis

      The agency will work closely with selected applicants to accelerate product development.
      U.S. Food and Drug Administration 05.31.18

    • Cardiovascular | Diagnostics
      Boston Scientific Launches HeartLogic Heart Failure Diagnostic in Europe

      Boston Scientific Launches HeartLogic Heart Failure Diagnostic in Europe

      First and only heart failure diagnostic tool proven to detect 70 percent of heart failure events several weeks in advance.
      PR Newswire 05.29.18

    • Cardiovascular | Surgical
      FDA Approves Abbott

      FDA Approves Abbott's Xience Sierra Everolimus-Eluting Coronary Stent

      New features help doctors treat more difficult-to-reach blockages in patients' arteries.
      PR Newswire 05.23.18


    • 3 Critical Considerations for U.S. Medical Device Commercialization

      3 Critical Considerations for U.S. Medical Device Commercialization

      The step-by-step process of working with the FDA to bring a medical device to the U.S.
      Michael Lynch, Managing Consultant, Intertek 05.18.18

    • Materials | Surgical
      Boston Scientific Responds to

      Boston Scientific Responds to '60 Minutes' Transvaginal Mesh Report

      The company released an open letter denying 60 Minutes' claims of using a counterfeit Chinese plastic for its mesh products.
      Boston Scientific 05.14.18

    Loading, Please Wait..

    Trending
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • FDA OKs J&J Vision's AcuVue Oasys Max 1-Day Contact Lenses
    • How To Overcome The Top 6 Medical Device Manufacturing Challenges
    • Cepheid, BioGX Partner To Create GeneXpert Monkeypox Test
    • Intermountain Healthcare & Siemens Healthineers Open 3 Tellica Outpatient Imaging Centers
    Breaking News
    • Enhatch Partners with Holo-Light to Deliver New Extended Reality Streaming Platform
    • Study Confirms Safety, Accuracy of Vectorious' V-LAP In-Heart Sensor
    • Norman Noble Achieves ISO 13485:2016 Certification
    • Indian SMEs Gaining Access to Russian Medtech Market Amid Ukraine Conflict
    • Quell Wearable Neuromodulation Device Wins De Novo Authorization
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • OEMs Seek Molders Offering Timely Techniques
    • Robotic Surgery: Cutting Through to the Latest
    • Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kensing Acquires Vitae Naturals
    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise
    Shiitake Mushroom Extract Appears Helpful in HPV Infections
    Coatings World

    Latest Breaking News From Coatings World

    PPG to Increase U.S. Aerospace Products Manufacturing Output to Meet Rising Demand
    Solvay to Discontinue Use of Fluorosurfactants for Production of Fluoropolymers
    AkzoNobel Names New CEO
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Study Confirms Safety, Accuracy of Vectorious' V-LAP In-Heart Sensor
    Norman Noble Achieves ISO 13485:2016 Certification
    Indian SMEs Gaining Access to Russian Medtech Market Amid Ukraine Conflict
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Shimadzu Scientific Instruments Extends HQ Campus
    Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
    Batavia Enters Commercial Manufacturing Business
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Naples Soap Company to Open New Store in Venice, Florida
    Nectar Recruits 8-Year-Old YouTube Star to Launch Her Own Bath & Body Line
    L'Oreal Exec Joins Function of Beauty
    Happi

    Latest Breaking News From Happi

    Rhode Island’s Department of Health, Raw Elements and Partners Expand Touch-Free Mineral Sunscreen
    Julee Wilson Named Executive Director of BeautyUnited
    Arey Launches Unisex Leave-In Conditioner
    Ink World

    Latest Breaking News From Ink World

    Amcor Lift-Off Initiative Shortlists Start-ups for Seed Funding
    Barentz Highlights Lincoln MFG’s New ISO 9001:2015 Certification
    Ingevity Appoints Christine Stunyo as Chief Human Resources Officer
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Eaglewood introduces Sitexco Label L10 anilox cleaning system
    Germark makes double press investment in Bobst
    UPM Raflatac to enhance service capabilities at Mills River factory
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Rockline's Springdale Campus Achieves 15 Million Safe Work Hours
    Emmanuelle Picard to Join Ahlstrom-Munksjö's Executive Management Team
    Alkegen Completes Luyang Acquisition
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Researchers Develop Microfluidic Sensors to Improve Implant Survival Rates
    Lawrence Yellin Appointed as Fuse Medical CFO
    Researchers Discover Novel Patching Material for Bone Defects
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Avery Dennison Highlights New Approach to Apparel with ADX Lab
    trinamiX Face Authentication Protects Users from Fraud Attacks During Mobile Payments
    Hugo Boss Partners with Nedap for Global RFID Roll-out

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login